Medicrea’s €20MM Financing to Support Patient-Specific UNiD Rods
Medicrea entered into agreements to raise €20MM (~US $22.4MM) to support commercialization of UNiD™ Patient-Specific Rods in the U.S. and new ex-U.S....
Medicrea entered into agreements to raise €20MM (~US $22.4MM) to support commercialization of UNiD™ Patient-Specific Rods in the U.S. and new ex-U.S....
Bioventus is reported to have delayed its US $150MM initial public offering. ...
Intellirod Spine raised >US $1.0MM in additional equity financing. Funds will be used to reach key milestones toward commercialization of...
Titan Spine closed a substantial round of financing. Proceeds will support U.S. sales expansion and surgeon adoption of Endoskeleton® titanium interbody...
Amedica priced an underwritten public offering for gross proceeds of US $11MM, prior to various deductions. Closing is expected to occur...
Bioventus registered for an initial public offering at a placeholder amount of $150MM....
Investors continue to tout healthcare IT as a strong space for funding, yet most of the backing in orthopaedics is...
ORTHOWORLD reported 18 funding announcements in 1H16, compared to 23 in 1H15. Similar to recent years, the spine market was...
SI-BONE closed a US $20MM round of growth capital financing. Proceeds will support U.S. sales expansion and R&D to develop new products to...
OrthoPediatrics filed to raise up to US $75MM in an initial public offering. The company plans to list on the NASDAQ...
Login
Register for a free account
As a guest member you get access to more articles and videos every month.